ArticleTropical medicine and health2025
Mortality burden of bacterial antimicrobial resistance in East Africa: pooled analysis of modelled estimates.
Article in Tropical medicine and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBacterial antimicrobial resistance (AMR) is a major and growing public health threat in East African Community (EAC) countries, where fragile health systems, inadequate diagnostics, and inappropriate antibiotic use drive high levels of resistant infections. Despite this, robust subregional mortality estimates remain limited.
methodsWe conducted a secondary pooled analysis of modelled, publicly available, country-level mortality estimates from the Global Research on Antimicrobial Resistance (GRAM) 2019 project. Data were extracted for six EAC countries: Burundi, Kenya, Rwanda, South Sudan, Tanzania, and Uganda. Because GRAM reports age-standardised mortality rates (ASMRs) with 95% uncertainty intervals, we derived standard errors from these intervals, assuming approximate normality, and used them in the pooled analysis. Using random-effects models with restricted maximum likelihood (REML), we pooled ASMRs per 100,000 population for deaths associated with and attributable to AMR. We calculated 95% confidence intervals and prediction intervals, assessed heterogeneity using I
resultsAcross the six EAC countries, there were an estimated 154,760 deaths associated with AMR and 36,480 deaths attributable to AMR in 2019. The pooled ASMR for AMR-associated deaths was 144.69 per 100,000 (95% CI 129.07-160.30) population, with a 95% prediction interval of 122.57-166.81. Country-specific ASMRs for AMR-associated deaths ranged from 129.5 per 100,000 population in Uganda to 167.0 per 100,000 population in Burundi. For AMR-attributable deaths, the pooled ASMR was 34.62 per 100,000 (95% CI 30.02-39.23) population, with a prediction interval of 28.10-41.14. Country-specific ASMRs for attributable deaths ranged from 30.80 per 100,000 population in Uganda to 41.90 per 100,000 population in Burundi. For both associated and attributable mortality, heterogeneity was negligible (I
conclusionThis pooled secondary analysis indicates a substantial and regionally consistent mortality burden from bacterial AMR in East Africa. The findings reify the need for coordinated investment in AMR surveillance, stewardship, and overall response across the EAC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.